Tectonic Therapeutic, Inc.

TECXNasdaqCIK 1681087HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 173 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Tectonic Therapeutic, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-06-1708:17 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-192746
2021-06-1416:30 ET	8-K	5.07 Shareholder vote results	0001564590-21-032790
2021-05-1316:53 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001564590-21-027619
2021-05-1307:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-159820
2021-05-0307:24 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-146637
2021-04-2216:19 ET	DEF 14A	Proxy statementPeriod 2021-06-10	0001564590-21-020116
2021-03-2308:03 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-090429
2021-03-1816:51 ET	10-K	Annual reportPeriod 2020-12-31	0001564590-21-014190
2021-03-1807:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-21-084892
2021-02-1616:02 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-21-044828
2021-02-0807:57 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-21-031585
2021-01-1107:01 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-005755
2020-11-2016:08 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-299395
2020-11-1709:07 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-295551
2020-11-1707:39 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-295466
2020-11-0517:05 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001564590-20-051456
2020-11-0507:18 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-286214
2020-10-2108:19 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-273355
2020-10-0608:29 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-264387
2020-10-0507:10 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-263234
2020-08-0607:11 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001564590-20-037237
2020-08-0607:07 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-211298
2020-07-0607:35 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001564590-20-031761
2020-06-1608:24 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001564590-20-029433
2020-06-0916:30 ET	8-K	5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001564590-20-028774
2020-05-1407:05 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-142191
2020-05-1307:06 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-141026
2020-05-0716:01 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001564590-20-022815
2020-05-0707:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-135565
2020-04-2216:30 ET	DEF 14A	Proxy statementPeriod 2020-06-04	0001564590-20-017934
2020-04-0308:01 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-097126
2020-03-3016:50 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-091030
2020-03-1616:02 ET	10-K	Annual reportPeriod 2019-12-31	0001564590-20-011144
2020-03-1607:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-073732
2020-02-1316:14 ET	8-K	1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-035577
2020-02-1016:09 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-20-029771
2020-01-1307:01 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-20-005881
2019-11-0716:01 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001564590-19-041704
2019-11-0707:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-286594
2019-10-0708:00 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-19-263223
2019-08-0807:21 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001564590-19-030417
2019-08-0807:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-216001
2019-08-0618:52 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-19-213159
2019-07-3017:25 ET	SC 13D	Ownership report, active investor	0001144204-19-036699
2019-07-1717:23 ET	8-K	1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-19-195748
2019-07-1507:07 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001193125-19-193574
2019-06-1207:35 ET	8-K	5.07 Shareholder vote results	0001193125-19-170745
2019-05-2321:13 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-19-154392
2019-05-1316:07 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001193125-19-145337
2019-05-1307:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-144763

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.